To demonstrate that MUS81 knockdown increases the antitumor effect of talazoparib in vivo, nude mice bearing MUS81-deficient and parental xenograft gastric cancer were treated daily with and without oral 0.33 mg/kg talazoparib. Here, MUS81 is linked to gastric cancer.